271 related articles for article (PubMed ID: 6584630)
1. Safety and efficacy of vaginal prostaglandin E2 suppositories in the management of third-trimester fetal demise.
Kent DR; Goldstein AI; Linzey EM
J Reprod Med; 1984 Feb; 29(2):101-2. PubMed ID: 6584630
[TBL] [Abstract][Full Text] [Related]
2. Association of extrauterine fetal death with failure of prostaglandin E2 suppositories.
Orr JW; Huddleston JF; Goldenberg RL; Knox GE; Davis RO
Obstet Gynecol; 1979 Mar; 53(3 Suppl):56S-58S. PubMed ID: 424129
[TBL] [Abstract][Full Text] [Related]
3. Prostaglandin E2 induction of labor for fetal demise.
Kent DR; Goldstein AI
Obstet Gynecol; 1976 Oct; 48(4):475-8. PubMed ID: 967387
[TBL] [Abstract][Full Text] [Related]
4. Management of intrauterine fetal demise and missed abortion using prostaglandin E2 vaginal suppositories.
Southern EM; Gutknecht GD
Obstet Gynecol; 1976 May; 47(5):602-6. PubMed ID: 1264407
[TBL] [Abstract][Full Text] [Related]
5. Cervical ripening with prostaglandin E2 vaginal suppositories.
Buchanan D; Macer J; Yonekura ML
Obstet Gynecol; 1984 May; 63(5):659-63. PubMed ID: 6585733
[TBL] [Abstract][Full Text] [Related]
6. A comparative study of two types of prostaglandins for abortion during the second trimester.
Rettenmaier MA; Hanson FW
Surg Gynecol Obstet; 1983 May; 156(5):585-8. PubMed ID: 6573807
[TBL] [Abstract][Full Text] [Related]
7. Vaginal prostaglandin E2 for interruption of pregnancy and management of intrauterine death.
Thiery M; Amy JJ; Decoster JM
Z Geburtshilfe Perinatol; 1979 Jun; 183(3):218-22. PubMed ID: 483950
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2 induction of abortion and fetal demise.
Wiley TL; Poole CP; Gookin KS; Wiser WL; Morrison JC
Int J Gynaecol Obstet; 1989 Feb; 28(2):171-5. PubMed ID: 2563705
[TBL] [Abstract][Full Text] [Related]
9. Induction of labor with prostaglandin E2 vaginal suppositories.
Macer J; Buchanan D; Yonekura ML
Obstet Gynecol; 1984 May; 63(5):664-8. PubMed ID: 6585734
[TBL] [Abstract][Full Text] [Related]
10. Priming of the uterine cervix with oral prostaglandin E2 in the term multigravida.
Weiss RR; Tejani N; Israeli I; Evans MI; Bhakthavathsalan A; Mann LI
Obstet Gynecol; 1975 Aug; 46(2):181-4. PubMed ID: 1097977
[TBL] [Abstract][Full Text] [Related]
11. A rare obstetric contraindication to the use of vaginal prostaglandins for fetal demise.
Waszak SJ
J Reprod Med; 1979 Apr; 22(4):204-6. PubMed ID: 458763
[TBL] [Abstract][Full Text] [Related]
12. Concentrated oxytocin plus low-dose prostaglandin E2 compared with prostaglandin E2 vaginal suppositories for second-trimester pregnancy termination.
Owen J; Hauth JC
Obstet Gynecol; 1996 Jul; 88(1):110-3. PubMed ID: 8684741
[TBL] [Abstract][Full Text] [Related]
13. Third-trimester uterine rupture after prostaglandin E2 use for labor induction.
Maymon R; Haimovich L; Shulman A; Pomeranz M; Holtzinger M; Bahary C
J Reprod Med; 1992 May; 37(5):449-52. PubMed ID: 1507193
[TBL] [Abstract][Full Text] [Related]
14. Cervical ripening: a randomized study comparing prostaglandin E2 gel to prostaglandin E2 suppositories.
Perryman D; Yeast JD; Holst V
Obstet Gynecol; 1992 May; 79(5 ( Pt 1)):670-2. PubMed ID: 1565347
[TBL] [Abstract][Full Text] [Related]
15. Third-trimester uterine rupture associated with vaginal prostaglandin E2.
Sawyer MM; Lipshitz J; Anderson GD; Dilts PV
Am J Obstet Gynecol; 1981 Jul; 140(6):710-1. PubMed ID: 7258248
[TBL] [Abstract][Full Text] [Related]
16. Use of prostaglandin E2 vaginal suppositories in third-trimester fetal demise.
Martin RW; Helman NS; Martin JN; Morrison JC
Int J Gynaecol Obstet; 1989 Jul; 29(3):269-71. PubMed ID: 2569427
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin vaginal suppositories: a simple and safe approach to the induction of labor.
Shepherd JH; Bennett MJ; Laurence D; Moore F; Sims CD
Obstet Gynecol; 1981 Nov; 58(5):596-600. PubMed ID: 6946350
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E2 vaginal suppositories in pregnancy with an anencephalic fetus.
Boehm FH; Killam AP; Chambers JF; Davidson KK
Obstet Gynecol; 1980 Jun; 55(6):758-60. PubMed ID: 7383465
[TBL] [Abstract][Full Text] [Related]
19. Management of intrauterine fetal death with prostaglandin E2 vaginal suppositories.
Lauersen NH; Cederqvist LL; Wilson KH
Am J Obstet Gynecol; 1980 Aug; 137(7):753-7. PubMed ID: 7405965
[TBL] [Abstract][Full Text] [Related]
20. Absence of maternal side effects from prostaglandins used for cervical ripening.
Goodlin RC; Reschl L; Clewell WH
J Reprod Med; 1986 Dec; 31(12):1095-7. PubMed ID: 3467066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
